Non-motor symptoms in Parkinson’s disease: an integrative review of prevalence, clinical features, and impact on quality of life
Abstract
Background: Parkinson’s disease (PD) is a multisystem neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra and the widespread aggregation of alpha-synuclein across multiple neural networks. In addition to the classic motor features, non-motor symptoms (NMS)—including sleep disturbances, neuropsychiatric, autonomic, and sensory alterations—are highly prevalent and may appear early in the disease course, serving as important prodromal markers. These symptoms have a substantial impact on patients’ quality of life (QoL). Objective: To synthesize and critically analyze recent evidence on non-motor symptoms in PD, focusing on their prevalence, clinical characteristics, and impact on quality of life. Methods: This integrative review was conducted using PubMed, SciELO, and the BVS database, including articles published over the last 10 years in English or Portuguese. Original studies, reviews, and cohort studies involving PD patients and addressing non-motor symptoms were included. The search strategy combined the descriptors “Parkinson disease” and “non-motor symptoms.” From a total of 562 identified articles, duplicates and non-relevant studies were excluded, resulting in 18 studies included in the final analysis. Results: More than 90% of patients with PD experience at least one non-motor symptom during the disease course, many of which may be present in early stages. Sleep disturbances are among the most prevalent NMS and are strongly associated with reduced quality of life. Excessive daytime sleepiness results from disruption of the sleep–wake cycle, increasing the risk of accidents and cognitive impairment. REM sleep behavior disorder is a key prodromal marker of synucleinopathies. Neuropsychiatric symptoms such as depression and anxiety contribute to social withdrawal and increased dependency. Autonomic dysfunctions, including constipation, reflect early involvement of the autonomic nervous system. Sensory disturbances, particularly hyposmia, are also common and may negatively affect eating enjoyment, safety, and emotional well-being. Overall, these findings support a caudo-rostral progression of PD, associated with alpha-synuclein deposition across different neural systems. Conclusion: Non-motor symptoms are highly prevalent, heterogeneous, and often precede motor manifestations in PD, with sleep disturbances being among the most sensitive indicators of early neurodegeneration. Early recognition of these features may enable earlier diagnosis, improved risk stratification, and more targeted interventions aimed at optimizing patients’ quality of life.